Lecture XI-XII Flashcards
COX-1
- Constitutively expressed
- Ubiquitous
- Protects gastric mucosa, helps platelet agreggation
COX-2
*Inducible in cell types with pro-inflammatory signals
- Induciblely expressed in: macrophages, monocytes, osteoblasts
- Constitutively expressed in : brain, kidney, endothelium
*Pro inflammatory response: Recruits inflammatory cells, sensitizes skin pain receptors, regulates hypothalamic temperature
synthesises prostaglandins that promote: INFLAMMATION, PAIN, FEVER
Periphery Prostaglandin effect on Pain
Primary Afferent Neurons- decreases activation threshold for pain so causes pain sensitization
Central prostaglandin effect on pain
Dorsal Horn Neurons- enhances depolarization of secondary sensory neurons causing CNS pain sensitization
COX-1 action on GI tract
- Decrease gastric acid secretion
- Decrease bicarb production
- Increase mucous production
NSAIDs decrease PG, which decreases protection= GASTRIC TOXICITY
Treatment:
- Misprostol- a PGE1 analog (Note: Caution in women/Abortifacient)
- Omeprazole- proton pump inhibitor (inhibits gastric acid production)
COX-1 action on CV system
Platelets: Only COX-1 (TXA2: vasoconstriction, platelet aggregation)
Endothelial Cells: COX-1 &2 (PGI2: vasodilator, inhibits platelet aggregation
If there is an imbalance between TXA2 and PGI2 it can cause either excessive bleeding or thrombosis.
TXA2
Vasoconstriction
Platelet Aggregation
PGI2
vasodilation
Inhibits platelet aggregation
COX-1 action on the Kidney
COX-1 &2 always present
PG’s increase vasodilation preventing ischemia
Increase the GFR and increase the Na+/water excretion
Help prevent vasoconstriction of renal vessels in disease.
NSAIDs decrease PG, decreasing the vasodilation= RENAL TOXICITY
Usually reversible with stop of NSAID
COX-1 on female repro
PG stimulate uterine contractions in child birth
COX-1 & Ductus Arteriosus
Blood from pulmonary artery to aorta to bypass the lungs
Ductus is kept open by PG’s
NSAIDs
During pregnancy- premature closure
After pregnancy- induce closure to help
Aspirin
Uses: Treatment of moderate pain, Inflammatory Diseases (decreases inflammation), Fever reduction, Prevention of cardiovascular events @ low doses, Cancer chemoprevention
Aspirin Doses
- 81 mg/day: Antiplatelet Activity NEED TO RULE OUT HEMORRHAGIC STROKE RISK
- ~2400 mg/day: Analgesic/Anti-pyretic
- 4,600-6,00 mg/day: Anti- Inflammatory
Aspirin Treatment of CV disease
Preminantly inhibits COX-1 activity in the platelets throughout the whole life span since they have no nucleus and can’t regenerate COX-1 so reduces the TXA2 (vasoconstriction, increases platelet aggregation).
Endothelial cells can regenerate COX-1 & have COX-2, low level aspirin does not affect the production of PGI2 (inhibitor of platelet aggregation & vasodilator)
Inhibiting TXA2 and not disturbing PGI2 production, provides an anti-thrombogenic anvironment
- At higher concentrations (anti-inflammatory ones), you increase the inhibition of PGI2 as well.
- Other NSAIDs inhibit COX-1 in platelets but are reversible so less effective.
Salsalate
Salicylate NSAID, less potent than aspirin but better for people at risk for GI toxicity or at risk for increased bleeding.
Highly protein bound so increased drug interactions with warfarin
Difulsinal
Does not cross the BBB so ineffective anti-pyretic
Less potent than aspirin but better for patients with increased risk of GI toxicity or increased risk of bleeding
Highly protein bound so increased drug interactions with warfarin
Salicylate Toxicity
*At low doses metabolized in liver, eliminated in first order but at high doses, eliminated by zero order kinetics since the enzymes are saturated
Intoxication: Metabolic acidosis, hypoglycemia, confusion, tremors, seizures, delerium, respiratory depression.
Treatment: Alkalization of the urine with Sodium Bicarb. Prevents reabsorption of drug in the renal tubule